Compare MSM & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MSM | TWST |
|---|---|---|
| Founded | 1941 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 7.9B |
| IPO Year | 1996 | 2018 |
| Metric | MSM | TWST |
|---|---|---|
| Price | $107.48 | $113.54 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 14 |
| Target Price | ★ $134.63 | $128.82 |
| AVG Volume (30 Days) | 891.4K | ★ 2.2M |
| Earning Date | 01-06-2027 | 11-12-2026 |
| Dividend Yield | ★ 3.32% | N/A |
| EPS Growth | ★ 11.48 | N/A |
| EPS | ★ 3.98 | N/A |
| Revenue | ★ $3,363,817,000.00 | $459,433,000.00 |
| Revenue This Year | $8.04 | $21.01 |
| Revenue Next Year | $5.94 | $18.75 |
| P/E Ratio | $26.94 | ★ N/A |
| Revenue Growth | 4.99 | ★ 22.00 |
| 52 Week Low | $78.80 | $28.27 |
| 52 Week High | $133.95 | $219.71 |
| Indicator | MSM | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 32.91 | 39.92 |
| Support Level | $101.50 | $82.66 |
| Resistance Level | $122.52 | $153.47 |
| Average True Range (ATR) | 3.97 | 14.84 |
| MACD | -0.76 | -1.94 |
| Stochastic Oscillator | 3.09 | 28.14 |
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations supplies. MSC primarily operates in North America, where it derives over 95% of its revenue.
Twist Bioscience Corp provides customizable solutions across the biological continuum, helping customers read, write and innovate in biology. The core of its business is a proprietary platform that allows it to manufacture synthetic DNA by writing DNA on a silicon chip. The company operates as one reportable and operating segment, through which it develops, manufactures and sells DNA Synthesis and Protein Solutions and NGS Applications products and services. It has presence in Americas, EMEA, and APAC. Majority of revenue comes from Americas. Its products are Genes, Oligo Pools, NGS, Variant Libraries, Synthetic Controls, Antibody Discovery, and VDR Solutions.